Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
2 months ago
8
ARTICLE AD BOX
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.